Q32 Bio (DB0) Financial Statements

2 Followers

Q32 Bio Financial Overview

Q32 Bio's market cap is currently €386.18M. The company's EPS TTM is €2.79; its P/E ratio is 5.39; Q32 Bio is scheduled to report earnings on August 5, 2026, and the estimated EPS forecast is €-0.27. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	$ 53.74M	$ 0.00	$ -6.65M	$ 6.65M	$ 0.00
Gross Profit	$ 53.74M	$ 0.00	$ -6.65M	$ 6.65M	$ 0.00
Operating Income	$ 16.90M	$ -66.10M	$ -48.26M	$ -39.23M	$ -36.69M
EBITDA	$ 31.31M	$ -44.50M	$ -47.76M	$ -38.85M	$ -36.65M
Net Income	$ 29.82M	$ -47.73M	$ -53.74M	$ -42.81M	$ -37.56M
Balance Sheet
Cash & Short-Term Investments	$ 48.30M	$ 77.97M	$ 25.62M	$ 175.03M	$ 155.87M
Total Assets	$ 61.78M	$ 92.33M	$ 47.06M	$ 229.53M	$ 211.72M
Total Debt	$ 15.34M	$ 18.90M	$ 50.84M	$ 29.95M	$ 23.93M
Net Debt	$ -32.95M	$ -59.06M	$ 25.22M	$ -4.04M	$ -84.45M
Total Liabilities	$ 19.76M	$ 86.66M	$ 229.98M	$ 51.54M	$ 42.07M
Stockholders' Equity	$ 42.01M	$ 5.67M	$ -182.92M	$ 177.98M	$ 169.65M
Cash Flow
Free Cash Flow	$ -33.54M	$ -67.79M	$ -18.68M	$ -13.44M	$ -112.15M
Operating Cash Flow	$ -33.54M	$ -67.72M	$ -18.68M	$ -10.96M	$ -109.75M
Investing Cash Flow	$ 7.00M	$ 19.93M	$ -5.00K	$ -2.47M	$ -50.79M
Financing Cash Flow	$ -3.13M	$ 95.14M	$ 406.00K	$ 30.07M	$ 52.17M

Currency in USD

Q32 Bio Earnings and Revenue History

Income Statement >

Q32 Bio Debt to Assets

Balance Sheet >

Q32 Bio Cash Flow

Cash Flow >

Q32 Bio Forecast EPS vs Actual EPS

Earnings >